BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8486432)

  • 21. Alkaline phosphatase activity in mouse teratoma.
    Berstine EG; Hooper ML; Grandchamp S; Ephrussi B
    Proc Natl Acad Sci U S A; 1973 Dec; 70(12):3899-903. PubMed ID: 4521215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Influence of cell-cell interaction upon differentiation of murine embryonal carcinoma cells].
    Sun JJ; Campione-Piccardo J; Craig J; McBurney MW
    Zhonghua Zhong Liu Za Zhi; 1987 Jan; 9(1):2-5. PubMed ID: 3595420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of teratocarcinoma cell differentiation. Effect of the inhibitors of DNA synthesis.
    Nishimune Y; Kume A; Ogiso Y; Matsushiro A
    Exp Cell Res; 1983 Jul; 146(2):439-44. PubMed ID: 6192006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A ts T mutant of Schmidt Ruppin strain of Rous sarcoma virus restricted at 39.5 degrees C for the morphological transformation and the tumorigenicity of chicken embryo fibroblasts.
    Poirier F; Lawrence D; Vigier P; Jullien P
    Int J Cancer; 1982 Jan; 29(1):69-76. PubMed ID: 6277805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Ad5 12S growth factor induces F9 cell proliferation and differentiation.
    Quinlan MP
    Oncogene; 1989 Aug; 4(8):1051-5. PubMed ID: 2569707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of in vitro differentiation of mouse embryonal carcinoma (F9) and erythroleukemia (MEL) cells by herbimycin A, an inhibitor of protein phosphorylation.
    Kondo K; Watanabe T; Sasaki H; Uehara Y; Oishi M
    J Cell Biol; 1989 Jul; 109(1):285-93. PubMed ID: 2745553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Murine embryonal carcinoma cells differentiate in vitro in response to retinol.
    Eglitis MA; Sherman MI
    Exp Cell Res; 1983 Jul; 146(2):289-96. PubMed ID: 6683658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polyoma virus mutants as probes of variety among mouse embryonal carcinoma cell lines.
    Georges E; Vasseur M; Blangy D
    Differentiation; 1982; 22(1):62-5. PubMed ID: 6286399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differentiation of embryonal carcinoma cells in response to retinoids.
    Abarzúa P; Sherman MI
    Methods Enzymol; 1990; 189():337-48. PubMed ID: 2292944
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of dietary retinoids upon growth and differentiation of tumors derived from several murine embryonal carcinoma cell lines.
    McCue PA; Thomas RS; Schroeder D; Gubler ML; Sherman MI
    Cancer Res; 1988 Jul; 48(13):3772-9. PubMed ID: 3378217
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Establishment and characterization of the pluripotent mouse teratocarcinoma cell line TCE.
    Wobus AM; Holzhausen H; Bloch C; Intek A; Becker K; Walter G; Forejt J; Schöneich J
    Biomed Biochim Acta; 1985; 44(11-12):1609-20. PubMed ID: 4091834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of protein phosphatase inhibition by okadaic acid on the differentiation of F9 embryonal carcinoma cells.
    Nishina Y; Sumi T; Iwai SA; Nishimune Y
    Exp Cell Res; 1995 Apr; 217(2):288-93. PubMed ID: 7698228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Murine embryonal carcinoma hybrids: decreased ability to spontaneously differentiate as a dominant trait.
    Oshima RG; McKerrow J; Cox D
    J Cell Physiol; 1981 Nov; 109(2):195-204. PubMed ID: 7197684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of F9 cell differentiation by transient exposure to retinoic acid.
    Dong JM; Li F; Chiu JF
    Biochem Biophys Res Commun; 1990 Jul; 170(1):147-52. PubMed ID: 1695505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hybrids between F9 "nullipotent" teratocarcinoma and rat thymus cells produce differentiated cells].
    Hsu WM; Song QB; Yao Z
    Shi Yan Sheng Wu Xue Bao; 1985 Jun; 18(2):177-87. PubMed ID: 3835750
    [No Abstract]   [Full Text] [Related]  

  • 36. Teratocarcinoma differentiation: plasminogen activator activity associated with embryoid body formation.
    Linney E; Levinson BB
    Cell; 1977 Feb; 10(2):297-304. PubMed ID: 189937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of 5-azacytidine treatment on mouse embryonal carcinoma cells.
    Cremisi C
    J Cell Physiol; 1983 Aug; 116(2):181-90. PubMed ID: 6190823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of a human ovarian teratocarcinoma-derived cell line.
    Zeuthen J; Nørgaard JO; Avner P; Fellous M; Wartiovaara J; Vaheri A; Rosén A; Giovanella BC
    Int J Cancer; 1980 Jan; 25(1):19-32. PubMed ID: 6931103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of specific protein tyrosine phosphatase transcripts during differentiation of mouse embryonal carcinoma (F9) cells.
    Tsuneizumi K; Kume T; Watanabe T; Gebbink MF; Thomas ML; Oishi M
    FEBS Lett; 1994 Jun; 347(1):9-12. PubMed ID: 8013668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of in vitro differentiation of mouse embryonal carcinoma (F9) cells by inhibitors of topoisomerases.
    Kondo K; Tsuneizumi K; Watanabe T; Oishi M
    Cancer Res; 1991 Oct; 51(19):5398-404. PubMed ID: 1680548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.